trending Market Intelligence /marketintelligence/en/news-insights/trending/_8NdmaRxSYRYkXybFucruw2 content esgSubNav
In This List

Transgenomic, Precipio merger secures stockholder approval

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Transgenomic, Precipio merger secures stockholder approval

Transgenomic Inc. received stockholder approval for its proposed merger with Precipio Diagnostics LLC.

Precipio Diagnostics stockholders also approved the deal.

The closing of the merger is still pending the combined company's $7 million private placement of preferred convertible securities and the conversion of all outstanding secured debt into preferred convertible securities.

The combined company will be renamed Precipio Inc. and be relisted on Nasdaq under the PRPO ticker symbol.